BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18537997)

  • 1. DLX5 expression is monoallelic and Dlx5 is up-regulated in the Mecp2-null frontal cortex.
    Miyano M; Horike S; Cai S; Oshimura M; Kohwi-Shigematsu T
    J Cell Mol Med; 2008 Aug; 12(4):1188-91. PubMed ID: 18537997
    [No Abstract]   [Full Text] [Related]  

  • 2. DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency.
    Schüle B; Li HH; Fisch-Kohl C; Purmann C; Francke U
    Am J Hum Genet; 2007 Sep; 81(3):492-506. PubMed ID: 17701895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
    Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
    Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imprinting status of paternally imprinted DLX5 gene in Japanese patients with Rett syndrome.
    Itaba-Matsumoto N; Maegawa S; Yamagata H; Kondo I; Oshimura M; Nanba E
    Brain Dev; 2007 Sep; 29(8):491-5. PubMed ID: 17363207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?
    Chadwick LH; Wade PA
    Curr Opin Genet Dev; 2007 Apr; 17(2):121-5. PubMed ID: 17317146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
    Bapat S; Galande S
    Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis and mutation detection of DLX5 and DLX6 in autism.
    Nakashima N; Yamagata T; Mori M; Kuwajima M; Suwa K; Momoi MY
    Brain Dev; 2010 Feb; 32(2):98-104. PubMed ID: 19195802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
    Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
    Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A story of respiratory genes].
    Denjean A
    Rev Mal Respir; 2012 Mar; 29(3):374-5. PubMed ID: 22440300
    [No Abstract]   [Full Text] [Related]  

  • 11. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain?
    Armstrong DD
    Brain Dev; 2005 Nov; 27 Suppl 1():S72-S76. PubMed ID: 16182497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study.
    Cassel S; Revel MO; Kelche C; Zwiller J
    Neurobiol Dis; 2004 Mar; 15(2):206-11. PubMed ID: 15006690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evf2 (Dlx6as) lncRNA regulates ultraconserved enhancer methylation and the differential transcriptional control of adjacent genes.
    Berghoff EG; Clark MF; Chen S; Cajigas I; Leib DE; Kohtz JD
    Development; 2013 Nov; 140(21):4407-16. PubMed ID: 24089468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion.
    Ibrahim A; Papin C; Mohideen-Abdul K; Le Gras S; Stoll I; Bronner C; Dimitrov S; Klaholz BP; Hamiche A
    Science; 2021 Jun; 372(6549):. PubMed ID: 34324427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.
    Samaco RC; Nagarajan RP; Braunschweig D; LaSalle JM
    Hum Mol Genet; 2004 Mar; 13(6):629-39. PubMed ID: 14734626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
    Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
    Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and analysis of the Rett syndrome-associated MeCP2- null rat model.
    Zhai W; Hu HX; Le L; Zhuang FF; Wang KZ; Zhao Y; Wang K; Liu XM; Sun D; Wang XY; Kuang SH; Hu KP
    Yi Chuan; 2016 Nov; 38(11):1004-1011. PubMed ID: 27867150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breeding and maintenance of an Mecp2-deficient mouse model of Rett syndrome.
    Jugloff DG; Logan R; Eubanks JH
    J Neurosci Methods; 2006 Jun; 154(1-2):89-95. PubMed ID: 16439027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.